{"entity":{"id":"binhui-biopharmaceutical","kind":"company","name":"Binhui Biopharmaceutical","aka":["Binhui Biopharmaceutical Co., Ltd."],"tldr":"Binhui Biopharmaceutical is a Chinese developer in Wuhan that sponsors 4 registered cancer trials of OH2 and HX008.","summary":"Binhui Biopharmaceutical appears on ClinicalTrials.gov as the industry sponsor of 4 interventional cancer trials (phase 1/2, 3), testing OH2, HX008 in solid tumor, gastrointestinal cancer, melanoma. OnCo records the company from the registry alone: the head office city comes from its registered name, and there are no website, funding or approval claims until they are sourced.","asOf":"2026-09-11","links":[{"label":"ClinicalTrials.gov: trials sponsored by Binhui Biopharmaceutical","url":"https://clinicaltrials.gov/search?spons=Binhui%20Biopharmaceutical"}],"tags":["ctgov-sponsor","china","registry-only"],"related":[],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":["nct03866525","nct07382531","nct04616443","nct05868707"],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"hq":"Wuhan, China","country":"CN","companyType":"biotech","investors":[],"funding":[]},"route":"/companies/binhui-biopharmaceutical/","neighbours":{"trial":[{"id":"nct07382531","kind":"trial","name":"OH2 Injection in Combination With BS006 Injection for Advanced Solid Tumors","route":"/trials/nct07382531/"},{"id":"nct04616443","kind":"trial","name":"OH2 Injection in Combination With HX008 for Melanoma.","route":"/trials/nct04616443/"},{"id":"nct05868707","kind":"trial","name":"OH2 Injection in Melanoma","route":"/trials/nct05868707/"},{"id":"nct03866525","kind":"trial","name":"OH2 Oncolytic Viral Therapy in Solid Tumors","route":"/trials/nct03866525/"}]}}